Millipore Sigma Vibrant Logo

437725 Lipoxin A₄, 15-epi - CAS 171030-11-8 - Calbiochem

View Products on Sigmaaldrich.com
437725
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
171030-11-8C₂₀H₃₂O₅

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
437725-25UG
Verifica della disponibilità in corso...
Disponibilità limitata
Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      Bottiglia di vetro 25 μg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      Richiedi il prezzo
      Description
      OverviewA epimeric lipoxin A4 (Cat. No. 437720) analog that is more potent and metabolically stable than LXA4. Exhibits anti-inflammatory properties and serves as a "stop signal" to excessive leukocyte trafficking/infiltration. Blocks TNF-α-induced IL-8 release in human enterocyte. It is also an important modulator of the many pharmacological actions caused by aspirin.
      Caution! Product contains volatile liquid. Keep product cold at all times.
      Catalogue Number437725
      Brand Family Calbiochem®
      SynonymsLXA₄-15-epi, 15(R)-LXA₄, Aspirin-triggered LXA₄, (5S,6R,15R)-5,6,15-Trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid
      References
      ReferencesWallace, J.L., and Fiorucci, S. 2003. Trends Pharmacol. Sci. 24, 323.
      Filep, J.G., et al. 2002. Adv. Exp. Med. Biol. 507, 223.
      Titos, E., et al. 1999. Am. J. Physiol. 277, C870.
      Gronert, K., et al. 1998. J. Exp. Med. 187, 1285.
      Maddox, J.F., et al. 1997. J. Biol. Chem. 272, 6972.
      Claria, J., et al. 1996. Mol. Med. 2, 583.
      Claria, J., and Serhan, C.N. 1995. Proc. Natl. Acad. Sci. USA 92, 9475.
      Serhan, C.N., et al. 1995. Biochemistry 34, 14609.
      Product Information
      CAS number171030-11-8
      ATP CompetitiveN
      FormLiquid
      FormulationIn Ethanol.
      Hill FormulaC₂₀H₃₂O₅
      Chemical formulaC₂₀H₃₂O₅
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetExhibits anti-inflammatory properties
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Flammable
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage ≤ -70°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw aliquot and freeze (-70°C).
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      437725-25UG 04055977186895

      Documentation

      Lipoxin A₄, 15-epi - CAS 171030-11-8 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Lipoxin A₄, 15-epi - CAS 171030-11-8 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      437725

      Riferimenti bibliografici

      Panoramica delle referenze
      Wallace, J.L., and Fiorucci, S. 2003. Trends Pharmacol. Sci. 24, 323.
      Filep, J.G., et al. 2002. Adv. Exp. Med. Biol. 507, 223.
      Titos, E., et al. 1999. Am. J. Physiol. 277, C870.
      Gronert, K., et al. 1998. J. Exp. Med. 187, 1285.
      Maddox, J.F., et al. 1997. J. Biol. Chem. 272, 6972.
      Claria, J., et al. 1996. Mol. Med. 2, 583.
      Claria, J., and Serhan, C.N. 1995. Proc. Natl. Acad. Sci. USA 92, 9475.
      Serhan, C.N., et al. 1995. Biochemistry 34, 14609.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-August-2008 RFH
      SynonymsLXA₄-15-epi, 15(R)-LXA₄, Aspirin-triggered LXA₄, (5S,6R,15R)-5,6,15-Trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid
      DescriptionAn epimeric lipoxin A4 (Cat. No. 437720) analog that is more potent and metabolically stable than LXA4. Exhibits anti-inflammatory properties and serves as a "stop signal" to excessive leukocyte trafficking/infiltration. Reported to block TNF-α-induced IL-8 release in human enterocytes. Also reported to be an important modulator of the pharmacological actions of aspirin.

      Caution! Product contains volatile liquid; keep cold at all times.
      FormLiquid
      FormulationIn Ethanol.
      Intert gas (Yes/No) Packaged under inert gas
      CAS number171030-11-8
      Chemical formulaC₂₀H₃₂O₅
      Structure formulaStructure formula
      Purity≥98% by HPLC
      Storage Protect from light
      ≤ -70°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw aliquot and freeze (-70°C).
      Toxicity Flammable
      ReferencesWallace, J.L., and Fiorucci, S. 2003. Trends Pharmacol. Sci. 24, 323.
      Filep, J.G., et al. 2002. Adv. Exp. Med. Biol. 507, 223.
      Titos, E., et al. 1999. Am. J. Physiol. 277, C870.
      Gronert, K., et al. 1998. J. Exp. Med. 187, 1285.
      Maddox, J.F., et al. 1997. J. Biol. Chem. 272, 6972.
      Claria, J., et al. 1996. Mol. Med. 2, 583.
      Claria, J., and Serhan, C.N. 1995. Proc. Natl. Acad. Sci. USA 92, 9475.
      Serhan, C.N., et al. 1995. Biochemistry 34, 14609.